Publications by authors named "Matthew Daley"
Background And Objectives: Vaccine doses provided outside the Advisory Committee on Immunization Practices for minimum and maximum ages of vaccination and minimum intervals between doses are considered invalid. Our objective was to quantify the prevalence of and factors associated with invalid doses among US children aged 0 to 35 months.
Methods: We analyzed provider-verified vaccination records from the nationally representative 2011-2020 National Immunization Survey-Child.
Introduction: This study investigated the differences between males and females in autonomic functions and cognitive performance during cold-air exposure and cold-water partial-immersion compared to a room temperature-air environment. Although several studies have investigated the effects of cold-air or cold-water exposures on autonomic function and cognitive performance, biological sex differences are often under-researched.
Methods: Twenty-two males and nineteen females participated in the current study.
Article Synopsis
- COVID-19 vaccinations, particularly the newly recommended monovalent XBB.1-strain vaccines for all individuals 6 months and older, are vital for protection against severe illness and death from COVID-19, especially as new strains like Omicron JN.1 and KP.2 are spreading in the U.S.! -
- As vaccine effectiveness decreases over time, the ACIP has advised that everyone 6 months and older should receive the 2024-2025 COVID-19 vaccines, which have been approved or authorized by the FDA, including those from Moderna and Pfizer-BioNTech for ages 12 and up, and under Emergency Use Authorization for younger children!* -
- The FDA also authorized Novava
Article Synopsis
- - The text highlights the importance of secure firearm storage in preventing youth firearm injuries and deaths in the U.S., with pediatric clinicians not consistently utilizing available programs despite recommendations from the American Academy of Pediatrics.
- - The study aimed to evaluate the effectiveness of two different support methods—an electronic health record template (nudge) and an enhanced version with additional clinic support (nudge+)—in promoting a secure firearm storage program during pediatric visits.
- - Conducted across 30 pediatric clinics in Michigan and Colorado, the trial sought to determine if the nudge+ approach would increase the delivery of the firearm storage program to at least 10% more eligible families compared to the nudge alone.
Purpose: Vaccine-associated enhanced disease (VAED) is a theoretical concern with new vaccines, although trials of authorized vaccines against SARS-CoV-2 have not identified markers for VAED. The purpose of this study was to detect any signals for VAED among adults vaccinated against coronavirus disease 2019 (COVID-19).
Methods: In this cross-sectional study, we assessed COVID-19 severity as a proxy for VAED among 400 adults hospitalized for COVID-19 from March through October 2021 at eight US healthcare systems.
Background: The study's objective was to examine national trends in patterns of under-vaccination in the United States.
Research Design And Methods: The National Immunization Survey-Child (NIS-Child) is an annual cross-sectional survey that collects provider-verified vaccination records from a large national probability sample of children. Records from the 2011-2021 NIS-Child were used to assess receipt of the combined 7-vaccine series by age 24 months.
Background: Antidepressants are among the most commonly prescribed medications, but evidence on comparative weight change for specific first-line treatments is limited.
Objective: To compare weight change across common first-line antidepressant treatments by emulating a target trial.
Design: Observational cohort study over 24 months.
Importance: COVID-19 vaccination is recommended throughout pregnancy to prevent pregnancy complications and adverse birth outcomes associated with COVID-19 disease. To date, data on birth defects after first-trimester vaccination are limited.
Objective: To evaluate the associated risks for selected major structural birth defects among live-born infants after first-trimester receipt of a messenger RNA (mRNA) COVID-19 vaccine.
Background: A Diversity, Equity, and Inclusion (DEI) Team at a university health science library created a checklist for inclusive language and conducted an assessment of their library's website, LibGuides, and physical and digital signage. Inclusive language was defined as "language that is free from words, phrases or tones that reflect prejudiced, stereotyped or discriminatory views of particular people or groups".
Case Presentation: The 32-item checklist facilitated the identification of gendered language, stereotypes, ableist language, racist language, stigmatizing language, slang, acronyms, and out-of-date terminology regarding physical and mental health conditions.
Objective: To assess whether a two-phase intervention was associated with improvements in antibiotic prescribing among nonhospitalized children with community-acquired pneumonia.
Study Design: In a large health care organization, a first intervention phase was implemented in September 2020 directed at antibiotic choice and duration for children 2 months through 17 years of age with pneumonia. Activities included clinician education and implementation of a pneumonia-specific order set in the electronic health record.
Article Synopsis
- The study investigated the potential link between COVID-19 vaccination during pregnancy and the risk of stillbirth, addressing concerns of vaccine hesitancy among pregnant individuals.
- A matched case-control approach was used, analyzing data from 276 confirmed stillbirths and 822 live births to assess any significant associations with vaccination status.
- Results indicated no significant association between COVID-19 vaccination and stillbirth risk, regardless of vaccine type, number of doses, or timing of vaccination, suggesting that vaccination does not increase the risk of stillbirth in pregnant individuals.
Article Synopsis
- COVID-19 vaccinations are effective in preventing severe illness and death but their impact on post-COVID conditions (PCC) is less understood, prompting a study to evaluate this association.
- The study analyzed electronic health records from over 161,000 vaccinated and unvaccinated COVID-19 patients from multiple healthcare systems, focusing on new diagnoses of PCC within six months after infection.
- Results showed that vaccinated individuals had a lower risk of several PCC categories, especially sensory and circulatory issues, while mental health disorders had a slightly higher risk in vaccinated individuals, indicating that vaccination may help reduce long-term COVID-19 consequences.
Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
MMWR Morb Mortal Wkly Rep
April 2024
Article Synopsis
- - COVID-19 is still a significant public health concern, especially for individuals aged 65 and older, who accounted for 67% of COVID-19-related hospitalizations from October 2023 to January 2024.
- - The CDC recommended that everyone aged 6 months and older receive the updated 2023-2024 COVID-19 vaccine to protect against severe illness, as the virus continues to circulate and variants are emerging.
- - Additionally, on February 28, 2024, it was advised that those aged 65 and older get an extra dose of the updated vaccine to boost their immunity and reduce the risk of severe outcomes, including death.
Background: Guidelines for the use of antihypertensives changed in 2014 and 2017. To understand the effect of these guidelines, we examined trends in antihypertensive prescriptions in the United States from 2010 to 2019 using a repeated cross-sectional design.
Methods And Results: Using electronic health records from 15 health care institutions for adults (20-85 years old) who had ≥1 antihypertensive prescription, we assessed whether (1) prescriptions of beta blockers decreased after the 2014 Eighth Joint National Committee (JNC 8) report discouraged use for first-line treatment, (2) prescriptions for calcium channel blockers and thiazide diuretics increased among Black patients after the JNC 8 report encouraged use as first-line therapy, and (3) prescriptions for dual therapy and fixed-dose combination among patients with blood pressure ≥140/90 mm Hg increased after recommendations in the 2017 Hypertension Clinical Practice Guidelines.
Article Synopsis
- - This study aimed to assess whether getting vaccinated with mRNA COVID-19 vaccines during pregnancy affects the risk of adverse pregnancy outcomes like preterm birth and small-for-gestational age infants.
- - Researchers analyzed data from over 55,000 individuals with live singleton pregnancies and found that 42.3% received one or two doses of the vaccine, with the vaccination rate varying across maternal demographics.
- - The results indicated that vaccinated individuals had a lower risk of preterm birth compared to unvaccinated individuals, but the vaccination did not significantly impact the risks of small-for-gestational age infants, gestational diabetes, gestational hypertension, or preeclampsia.
Importance: Delays in receiving vaccinations lead to greater vaccine-preventable disease risk. Timeliness of receipt of recommended vaccinations is not routinely tracked in the US, either overall or for populations that have known barriers to accessing routine health care, including lower-income families and children.
Objective: To measure vaccination timeliness among US children aged 0 to 19 months, overall and by socioeconomic indicators.
Importance: Pregnant people and infants are at high risk of severe COVID-19 outcomes. Understanding changes in attitudes toward COVID-19 vaccines among pregnant and recently pregnant people is important for public health messaging.
Objective: To assess attitudinal trends regarding COVID-19 vaccines by (1) vaccination status and (2) race, ethnicity, and language among samples of pregnant and recently pregnant Vaccine Safety Datalink (VSD) members from 2021 to 2023.
Objective: To assess the validity of electronic health record (EHR)-based influenza vaccination data among adults in a multistate network.
Methods: Following the 2018-2019 and 2019-2020 influenza seasons, surveys were conducted among a random sample of adults who did or did not appear influenza-vaccinated (per EHR data) during the influenza season. Participants were asked to report their influenza vaccination status; self-report was treated as the criterion standard.
Purpose Of Review: Completion of all doses in multidose vaccine series provides optimal protection against preventable infectious diseases. In this review, we describe clinical and public health implications of multidose vaccine series noncompletion, including current challenges to ensuring children receive all recommended vaccinations. We then highlight actionable steps toward achieving early childhood immunization goals.
View Article and Find Full Text PDFArticle Synopsis
- * The CDC formed an independent group called the ACIP COVID-19 Vaccine Safety Technical Work Group (VaST) to monitor vaccine safety and address any concerns that arose post-authorization.
- * VaST met regularly from November 2020 to April 2023, collaborating with federal agencies to review safety data and inform vaccination policies while ensuring the effective assessment of safety during the rollout of multiple COVID-19 vaccines.
At its October 2023 meeting, the Advisory Committee on Immunization Practices* (ACIP) approved the Recommended Adult Immunization Schedule for Ages 19 Years or Older, United States, 2024. The adult immunization schedule, which can be found on the CDC immunization schedule website (https://www.cdc.
View Article and Find Full Text PDFAt its October 2023 meeting, the Advisory Committee on Immunization Practices* (ACIP) approved the Recommended Child and Adolescent Immunization Schedule for Ages 18 Years or Younger, United States, 2024. The child and adolescent immunization schedule, which can be found on the CDC immunization schedule website (https://www.cdc.
View Article and Find Full Text PDFArticle Synopsis
- - COVID-19 vaccines have been a significant success in reducing hospitalizations and deaths in the U.S., with over 675 million doses given and over 80% of the population receiving at least one dose.
- - The vaccines are estimated to have prevented more than 18 million hospitalizations and 3 million deaths, despite over one million fatalities from COVID-19 during the pandemic.
- - The Advisory Committee on Immunization Practices (ACIP) has actively reviewed data and made recommendations on COVID-19 vaccines, emphasizing their safety and effectiveness as key tools in combating serious illness from the virus.
Article Synopsis
- A study explored racial and ethnic disparities in influenza vaccination coverage among pregnant women in the U.S., finding that non-Hispanic White women had higher vaccination rates than Hispanic and non-Hispanic Black women.
- The research involved surveys conducted after the 2019-2020 and 2020-2021 flu seasons, with significant oversampling of non-Hispanic Black and unvaccinated women to assess vaccine-related attitudes influencing vaccination coverage.
- The study concluded that attitudes towards the vaccine (like safety concerns) significantly contributed to the observed disparities in vaccination rates, even in a context where overall vaccination coverage was relatively high among pregnant women.